CXCL13 and breast carcinoma: Meanwhile, Cohen et al. analyzed the scRNA-seq data obtained from 36 patients with breast cancer; then, they also revealed that the counts of CD4+PD-1+CXCL13+ T cells had significantly increased after receiving anti-PD-1 therapy [44].